4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,
Ibrolipim,
NO 1886,
NO-1886,
Ibrolipim,
NO-1886,
133208-93-2,
Lipoprotein Lipase Activator,
Ibrolipim [USAN:INN],
OPF 009,
4-Diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,
OPF-009,
UNII-07H1561618,
Phosphonic acid, ((4-(((4-bromo-2-cyanophenyl)amino)carbonyl)phenyl)methyl)-, diethyl ester,
07H1561618,
Diethyl 4-((4-bromo-2-cyanophenyl)carbamoyl)benzylphosphonate,
diethyl 4-[(4-bromo-2-cyanoanilino)carbonyl]benzylphosphonate,
Diethyl-4-((4-Bromo-2-cyanophenyl)carbamoyl)benzylphosphonate,
Diethyl (4-((4-bromo-2-cyanophenyl)carbamoyl)benzyl)phosphonate,
C19H20BrN2O4P,
Diethyl 4-[(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate,
Phosphonic acid, [[4-[[(4-bromo-2-cyanophenyl)amino]carbonyl]phenyl]methyl]-, diethyl ester,
NO 1886,
ACMC-20ejl0,
Ibrolipim (USAN/INN),
AC1L2ZH1,
MLS006011667,
CHEMBL34234,
SCHEMBL493918,
CTK0H6101,
DTXSID20157989,
KPRTURMJVWXURQ-UHFFFAOYSA-N,
ZINC1552570,
IN1270,
AKOS005067076,
MCULE-4026084248,
SS-3273,
KS-0000184M,
NCGC00481428-01,
SMR002529695,
LS-172861,
RT-013581,
D03747,
J-006332,
4-diethoxyphosphinoylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,
Diethyl (4-((4-bromo-2-cyanophenyl)carbamoyl)benzyl)phosphonate,
diethyl 4-[N-(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate,
N-(4-bromo-2-cyanophenyl)-4-(diethoxyphosphorylmethyl)benzamide,
Ibrolipim < Prop INN,
D0SA3J,
C19-H20-Br-N2-O4-P,
CID131601,
Lipoprotein Lipase Activator and NO-1886,
C082137,
4-[N-(4-Bromo-2-cyanophenyl)carbamoyl]benzylphosphonic acid diethyl ester,